This HTML5 document contains 182 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40016363
rdf:type
wikibase:Item
schema:description
scientific article published on 6 January 2016 επιστημονικό άρθρο מאמר מדעי 2016年论文 artículo científico publicado en 2016 tudományos cikk 2016年論文 ৬ জানুয়ারি ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak 2016年论文 bilimsel makale teaduslik artikkel научная статья bài báo khoa học vědecký článek artigo científico article científic videnskabelig artikel artikull shkencor artículu científicu espublizáu en 2016 articol științific 2016年论文 2016 nî lūn-bûn artikel ilmiah scientific article published on 6 January 2016 2016年論文 artigo científico articolo scientifico مقالة علمية نشرت في 6 يناير 2016 2016年の論文 tieteellinen artikkeli 2016年论文 2016年論文 2016 թվականի հունվարի 6-ին հրատարակված գիտական հոդված wissenschaftlicher Artikel 2016年论文 სამეცნიერო სტატია научни чланак scienca artikolo artykuł naukowy artikulong pang-agham 2016년 논문 научни чланак vitskapeleg artikkel научна статия vedecký článok บทความทางวิทยาศาสตร์ scientific article published on 6 January 2016 2016年論文 artigo científico wetenschappelijk artikel article scientifique 2016年论文 2016年論文 vetenskaplig artikel наукова стаття, опублікована в січні 2016 vitenskapelig artikkel article scientific мақолаи илмӣ
p:P577
wds:Q40016363-746CEC19-F255-4E5C-B6B4-2D9718D912CA
wdt:P577
2016-01-06T00:00:00Z
p:P2860
wds:Q40016363-045C58CE-178D-4156-9594-C00097C0F794 wds:Q40016363-49611754-8732-40F8-9BF4-15ED6789F43A wds:Q40016363-4AAF9ED2-566C-4B30-A974-A09BFF3CB8BB wds:Q40016363-3FDDD50C-58D8-4885-88CA-CA8393DE35AC wds:Q40016363-43F5B562-7053-48D7-ADAC-10132483A7B6 wds:Q40016363-22B7C6B7-E6F6-4FF8-AA41-755C96340B71 wds:Q40016363-1311130C-B612-44E6-9348-9A27BDD0C290 wds:Q40016363-18D13F96-819B-445F-A12F-C0EB4CE3A1BE wds:Q40016363-7E66F35C-69EA-4E34-8CD7-C306C5C604C1 wds:Q40016363-85AD9F81-0027-4768-8926-FA0B6ECB7576 wds:Q40016363-94AC5566-EE4B-4CD1-B063-238E41D80B4D wds:Q40016363-7953007E-3366-4193-A237-64A205348712 wds:Q40016363-7D52A74A-8750-4584-ADB4-6BB175D4E26F wds:Q40016363-63C01310-32CF-4F04-BF1B-70D1DAB02DE8 wds:Q40016363-6A7579E2-BB84-4437-B0F1-8C4321459BD0 wds:Q40016363-55AD569A-BE6E-41A2-B261-A43EB9283CAC wds:Q40016363-58089788-F8FD-49B0-A3E0-24B0EACA3163 wds:Q40016363-D6505A66-1F6D-4F4D-9ED9-C5EBE5C641A3 wds:Q40016363-DFFF029C-F75E-45BB-9F64-2884F4A6537A wds:Q40016363-E10B7B63-4A32-42E0-8F21-E8828E5305BB wds:Q40016363-C9DE73B5-649B-473D-9BC6-D33C9FFA84B1 wds:Q40016363-D166C27A-A699-49C3-8FBB-FB289C0AFA21 wds:Q40016363-AAFA86BC-2E80-46DA-8B47-29E7FA52D015 wds:Q40016363-BB1F0FB6-24B1-4DBC-9EA8-5AC2FEBABA4C wds:Q40016363-9F187FC3-8A6C-4DFA-B1D3-8C350F2043BF wds:Q40016363-EEA4F7D3-DEC3-4021-9DE6-5157136131FD wds:Q40016363-F322F38C-7A7B-4D73-96F4-384DEEAAABF1 wds:Q40016363-EB01D9A5-4DDF-4C60-9F1D-5603C5A1D595 wds:Q40016363-015F7679-7755-4812-98F1-1F518217A581
wdt:P2860
wd:Q36728517 wd:Q44835179 wd:Q35895168 wd:Q24201015 wd:Q37136845 wd:Q87492717 wd:Q45272022 wd:Q36235355 wd:Q84135415 wd:Q33637113 wd:Q33391560 wd:Q53226595 wd:Q37394831 wd:Q24633053 wd:Q42677947 wd:Q34240908 wd:Q42628839 wd:Q27687107 wd:Q38223081 wd:Q45283819 wd:Q38161520 wd:Q51060574 wd:Q50780747 wd:Q39158923 wd:Q35062156 wd:Q53147373 wd:Q34544918 wd:Q64386237 wd:Q48692208
p:P2093
wds:Q40016363-0A56EB7D-7C19-4715-A1A3-6F65B2AE343D wds:Q40016363-2A3E5CE9-DA99-4A7B-8DD5-0417740FEF00 wds:Q40016363-3B04E645-0C49-4FB2-A364-291663A5D601 wds:Q40016363-01C614CC-E88C-47DF-B4E6-42429137B6F4 wds:Q40016363-EB704611-EB9E-4DA6-B989-0719BE4CC144 wds:Q40016363-CD7C815B-8A55-47E4-84D4-02AF47F0C3F9 wds:Q40016363-DEB7B8E9-3430-41DF-B405-93E7DEA862C0 wds:Q40016363-A34E9EC1-CA50-4C3F-99D7-9EE2A013DB63 wds:Q40016363-978F0950-EAC0-4F9F-B1B3-21A3E3A8A555 wds:Q40016363-B88D93A9-18DA-413F-A84A-139FF1C8415C wds:Q40016363-6C9D1098-5B89-400B-8E78-5508DB8295B1
wdt:P2093
Tone Enden CaVenT Study Group Anne Mette Njaaastad Carl-Erik Slagsvold Pål Andre Holme Geir Hafsahl Ole Grøtta Nils-Einar Kløw Gunnar Sandbæk Ylva Haig Lars Olaf Holmen
rdfs:label
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
skos:prefLabel
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
schema:name
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
p:P50
wds:Q40016363-B538F387-D8CF-4AB3-8953-B6811C4024AB wds:Q40016363-58EDC968-B197-4306-A0A7-4399A2CCF2D9 wds:Q40016363-47BFCD60-7DA1-403E-9EC7-6BA2B85712E2
wdt:P50
wd:Q53184279 wd:Q90196464 wd:Q38544475
p:P1476
wds:Q40016363-47BCBDF2-CD1F-4E6C-A827-9DE8248349E1
wdt:P1476
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
p:P304
wds:Q40016363-EB61EEA7-72A7-4126-B19F-7CC9DEC240E3
wdt:P304
e64-71
p:P31
wds:Q40016363-1691F41A-E047-498F-ACBA-37C902902EA9
wdt:P31
wd:Q13442814
p:P921
wds:Q40016363-6B72EE6C-2BBA-43A5-80F0-381DECC2C8D2 wds:Q40016363-257A94A3-7D5A-4BD4-872C-A1C06C10A966 wds:Q40016363-4943BC79-4DB1-4F6D-9C03-24CBE0FF769A wds:Q40016363-E8C7F4F0-3731-4698-A6D9-98EE9A53A211 wds:Q40016363-62E02C5F-9938-43FC-85CE-F99094DCAD3D
wdt:P921
wd:Q2312472 wd:Q261327 wd:Q382091 wd:Q1762339 wd:Q1931577
p:P698
wds:Q40016363-53067ED9-17D2-4DCF-9177-A75BD82EFE6C
wdtn:P698
n10:26853645
wdt:P698
26853645
p:P1433
wds:Q40016363-80D99079-18F6-49D5-A380-0D560DF3A66F
wdt:P1433
wd:Q26840042
p:P433
wds:Q40016363-5BA73A62-5F3C-4582-A2E3-29639E6D4CC8
p:P478
wds:Q40016363-C7E6ADE2-C578-44A2-AFE6-7B35D6409D8C
wdt:P433
2
wdt:P478
3
p:P356
wds:Q40016363-98C82B50-CC94-493E-BE52-26BF528D6C76
wdtn:P356
n9:S2352-3026(15)00248-3
wdt:P356
10.1016/S2352-3026(15)00248-3